How Does Stronger Protection of Intellectual Property Rights Affect National Pharmaceutical Expenditure? An Analysis of OECD Countries
| DC Field | Value |
|---|---|
| dc.contributor.author | Youn Jung |
| dc.contributor.author | Soonman Kwon |
| dc.date.accessioned | 2019-02-11T07:09:25Z |
| dc.date.available | 2019-02-11T07:09:25Z |
| dc.date.issued | 2018-10-01 |
| dc.identifier.issn | 0020-7314 |
| dc.identifier.uri | https://repository.kihasa.re.kr/handle/201002/31125 |
| dc.format.extent | 17 |
| dc.language | eng |
| dc.publisher | Sage Publications |
| dc.title | How Does Stronger Protection of Intellectual Property Rights Affect National Pharmaceutical Expenditure? An Analysis of OECD Countries |
| dc.type | Article |
| dc.type.local | Article(Academic) |
| dc.subject.keyword | intellectual property right |
| dc.subject.keyword | patent |
| dc.subject.keyword | pharmaceutical expenditure |
| dc.subject.keyword | high-income countries |
| dc.contributor.affiliatedAuthor | Youn Jung |
| dc.identifier.doi | 10.1177/0020731418786095 |
| dc.identifier.url | https://doi.org/10.1177/0020731418786095 |
| dc.identifier.localId | KIHASA-1728 |
| dc.citation.title | The International Journal of Health Services |
| dc.citation.volume | 48 |
| dc.citation.number | 4 |
| dc.citation.date | 2018 |
| dc.citation.startPage | 685 |
| dc.citation.endPage | 701 |
| dc.identifier.bibliographicCitation | The International Journal of Health Services, vol. 48, no. 4, pp. 685 - 701 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
